- US11999733utility2024Diacylglycerol Kinase Modulating Compounds0 cites
- USD1028737design2024Blister Pack0 cites
- US11993583utility2024Therapeutic Compounds0 cites
- USD1027663design2024Blister Pack0 cites
- US11987617utility2024Antibodies That Target HIV GP120 and Methods of Use0 cites
- US11980609utility2024LPA Receptor Antagonists and Uses Thereof0 cites
- US11975017utility2024Compositions Comprising an RNA Polymerase Inhibitor and Cyclodextrin for Treating Viral Infections0 cites
- US11975012utility2024Remdesivir Treatment Methods0 cites
- US11976072utility2024Diacylglycerol Kinase Modulating Compounds0 cites
- US11976071utility2024Substituted Pyrrolo[1,2-b]pyridazines as Bifunctional Degraders of Interleukin-1 Receptor-associated Kinases0 cites
- US11976083utility2024Inhibitors of Peptidylarginine Deiminases0 cites
- US11963961utility2024Combination Therapy Comprising an ACC Inhibitor0 cites
- US11963967utility2024Phospholipid Compounds and Uses Thereof0 cites
- US11957693utility2024Combination MCL-1 Inhibitors with Anti-cancer Agents0 cites
- US11944611utility2024Capsid Inhibitors for the Treatment of HIV0 cites
- USD1019381design2024Pharmaceutical Package0 cites
- US11939318utility2024LPA Receptor Antagonists and Uses Thereof0 cites
- US11939347utility20241′-cyano Nucleoside Analogs and Uses Thereof0 cites
- US11931424utility2024Combination MCL-1 Inhibitors with Anti-body Drug Conjugates0 cites
- US11932634utility2024Diacylglycerol Kinase Modulating Compounds0 cites